Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT00054184

Public ClinicalTrials.gov record NCT00054184. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 4, 2026, 4:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

CT-2103 vs Docetaxel for the Second-Line Treatment of Non-Small Cell Lung Cancer (NSCLC): A Phase III Study

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known whether polyglutamate paclitaxel is more effective than docetaxel in treating non-small cell lung cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of polyglutamate paclitaxel with that of docetaxel in treating patients who have progressive non-small cell lung cancer.

Study identification

NCT ID
NCT00054184
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
CTI BioPharma
Industry
Enrollment
350 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 120 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 2003 (Actual)
Primary completion
Oct 2004 (Actual)
Completion
Oct 2004 (Actual)
Last update posted
Oct 5, 2020

2003 – 2004

United States locations

U.S. sites
35
U.S. states
23
U.S. cities
35
Facility City State ZIP Site status
Clinical Research Consultants, Incorporated Hoover Alabama 35216 —
Arizona Clinical Research Center Tucson Arizona 85712 —
Highlands Oncology Group - Springdale Springdale Arkansas 72764 —
Pacific Cancer Medical Center, Incorporated Anaheim California 92801 —
Synergy Hematology/Oncology Medical Associates Encino California 91316 —
California Cancer Care, Inc. Greenbrae California 94904-2007 —
California Hematology/Oncology Medical Group Torrance California 90505 —
Northwest Oncology and Hematology Associates Coral Springs Florida 33065 —
Florida Oncology Associates Jacksonville Florida 32207 —
Hematology Oncology Associates of theTreasure Coast - Port St. Lucie Port Saint Lucie Florida 34952 —
Suburban Hematology-Oncology Snellville Georgia 30078-6782 —
Gross Point Medical Center Skokie Illinois 60077 —
Western Kentucky Hematology/Oncology Group Paducah Kentucky 42003 —
Kentucky Cancer Clinic Pikeville Kentucky 41501 —
Saint Joseph Oncology, Incorporated Saint Joseph Missouri 64507 —
Montana Cancer Specialists Missoula Montana 59807-7877 —
Las Vegas Cancer Center Las Vegas Nevada 89102 —
Not listed Howell Township New Jersey 07731 —
Morristown Memorial Hospital Morristown New Jersey 07962 —
New Mexico Oncology-Hematology Consultants, Limited Albuquerque New Mexico 87109 —
Queens Medical Associates, PC Fresh Meadows New York 11365 —
Piedmont Oncology Specialist, II, PLLC Monroe North Carolina 28110 —
Odyssey Research Services Bismarck North Dakota 58501 —
Gabrail Cancer Center - Canton Office Canton Ohio 44718 —
Ireland Cancer Center Cleveland Ohio 44106-5065 —
Pennsylvania Oncology Hematology Associates Philadelphia Pennsylvania 19106 —
Charleston Hematology-Oncology, P.A. Charleston South Carolina 29403 —
Tri County Oncology Associates Rock Hill South Carolina 29732-1119 —
Santee Hematology Oncology Sumter South Carolina 29150 —
Family Cancer Center Collierville Tennessee 38017 —
Southwest Regional Cancer Center Austin Texas 78705 —
Not listed Richardson Texas 75080 —
Danville Hematology and Oncology, Incorporated Danville Virginia 24541 —
Virginia Oncology Care P.C. Richlands Virginia 24641 —
Western Washington Medical Group Everett Washington 98201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00054184, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 5, 2020 · Synced Oct 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00054184 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →